BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 21126610)

  • 1. Risk reduction for cardiac events after primary coronary intervention compared with thrombolysis for acute ST-elevation myocardial infarction (five-year results of the Swedish early decision reperfusion strategy [SWEDES] trial).
    Aasa M; Dellborg M; Herlitz J; Svensson L; Grip L
    Am J Cardiol; 2010 Dec; 106(12):1685-91. PubMed ID: 21126610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI).
    Danchin N; Coste P; Ferrières J; Steg PG; Cottin Y; Blanchard D; Belle L; Ritz B; Kirkorian G; Angioi M; Sans P; Charbonnier B; Eltchaninoff H; Guéret P; Khalife K; Asseman P; Puel J; Goldstein P; Cambou JP; Simon T;
    Circulation; 2008 Jul; 118(3):268-76. PubMed ID: 18591434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost and health outcome of primary percutaneous coronary intervention versus thrombolysis in acute ST-segment elevation myocardial infarction-Results of the Swedish Early Decision reperfusion Study (SWEDES) trial.
    Aasa M; Henriksson M; Dellborg M; Grip L; Herlitz J; Levin LA; Svensson L; Janzon M
    Am Heart J; 2010 Aug; 160(2):322-8. PubMed ID: 20691839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to treatment and three-year mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction-a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) substudy.
    Maeng M; Nielsen PH; Busk M; Mortensen LS; Kristensen SD; Nielsen TT; Andersen HR;
    Am J Cardiol; 2010 Jun; 105(11):1528-34. PubMed ID: 20494656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does diabetes mellitus abolish the beneficial effect of primary coronary angioplasty on long-term risk of reinfarction after acute ST-segment elevation myocardial infarction compared with fibrinolysis? (A DANAMI-2 substudy).
    Madsen MM; Busk M; Søndergaard HM; Bøttcher M; Mortensen LS; Andersen HR; Nielsen TT;
    Am J Cardiol; 2005 Dec; 96(11):1469-75. PubMed ID: 16310424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to reperfusion in acute myocardial infarction. It is time to reduce it!
    Barbagelata A; Perna ER; Clemmensen P; Uretsky BF; Canella JP; Califf RM; Granger CB; Adams GL; Merla R; Birnbaum Y
    J Electrocardiol; 2007 Jul; 40(3):257-64. PubMed ID: 17478179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry).
    Koeth O; Zahn R; Gitt AK; Bauer T; Juenger C; Senges J; Zeymer U;
    Am J Cardiol; 2009 Oct; 104(8):1074-7. PubMed ID: 19801027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of ST resolution analysis performed immediately versus at ninety minutes after primary percutaneous coronary intervention.
    Kumar S; Sivagangabalan G; Hsieh C; Ryding AD; Narayan A; Chan H; Burgess DC; Ong AT; Sadick N; Kovoor P
    Am J Cardiol; 2010 Feb; 105(4):467-74. PubMed ID: 20152240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and prognostic implications of ST-segment deviations from ambulatory Holter monitoring after ST-segment elevation myocardial infarction treated with either fibrinolysis or primary percutaneous coronary intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy).
    Idorn L; Høfsten DE; Wachtell K; Mølgaard H; Egstrup K;
    Am J Cardiol; 2007 Sep; 100(6):937-43. PubMed ID: 17826373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender differences in the outcome of cardiac interventions.
    Tillmanns H; Waas W; Voss R; Grempels E; Hölschermann H; Haberbosch W; Waldecker B
    Herz; 2005 Aug; 30(5):375-89. PubMed ID: 16132240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modalities of treatment and 30-day outcomes of unselected patients older than 75 years with acute ST-elevation myocardial infarction: data from the BLITZ study.
    De Luca L; Bolognese L; Casella G; Savonitto S; Gonzini L; Di Chiara A; De Servi S; Notaristefano S; Valagussa L; Maggioni AP; Chiarella F;
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1045-51. PubMed ID: 18799968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial.
    Gibson CM; Murphy SA; Montalescot G; Morrow DA; Ardissino D; Cohen M; Gulba DC; Kracoff OH; Lewis BS; Roguin N; Antman EM; Braunwald E;
    J Am Coll Cardiol; 2007 Jun; 49(23):2238-46. PubMed ID: 17560287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of acute ST-segment elevation myocardial infarction in West Pomerania province of Poland. Comparison between primary coronary intervention and thrombolytic therapy.
    Dryja T; Kornacewicz-Jach Z; Goracy J; Przybycień K; Jodko L; Skowronek A; Kurowski M; Zinka E
    Kardiol Pol; 2006 Jun; 64(6):591-9; discussion 600-1. PubMed ID: 16810577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-hospital and one-year outcomes of patients with high-risk acute myocardial infarction treated with thrombolysis or primary coronary angioplasty.
    Steffenino G; Santoro GM; Maras P; Mauri F; Ardissino D; Violini R; Chiarella F; Lucci D; Marini M; Baldasseroni S; Maggioni AP;
    Ital Heart J; 2004 Feb; 5(2):136-45. PubMed ID: 15086144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of mortality benefit of immediate thrombolytic therapy versus delayed primary angioplasty for acute myocardial infarction.
    Kent DM; Ruthazer R; Griffith JL; Beshansky JR; Grines CL; Aversano T; Concannon TW; Zalenski RJ; Selker HP
    Am J Cardiol; 2007 May; 99(10):1384-8. PubMed ID: 17493465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High mortality with ST elevation myocardial infarction in a nontrial setting.
    Shufelt KA; Paradiso-Hardy FL; Papastergiou J; Cohen EA
    Can J Cardiol; 2004 Dec; 20(14):1455-9. PubMed ID: 15614341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of postprocedural sustained ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention (from the HORIZONS-AMI Trial).
    Mehta RH; Yu J; Piccini JP; Tcheng JE; Farkouh ME; Reiffel J; Fahy M; Mehran R; Stone GW
    Am J Cardiol; 2012 Mar; 109(6):805-12. PubMed ID: 22196782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grade 3 ischemia on admission electrocardiogram and chest pain duration predict failure of ST-segment resolution after primary percutaneous coronary intervention for acute myocardial infarction.
    McGehee JT; Rangasetty UC; Atar S; Barbagelata NN; Uretsky BF; Birnbaum Y
    J Electrocardiol; 2007 Jan; 40(1):26-33. PubMed ID: 17067628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Routine early coronary angioplasty versus ischaemia-guided angioplasty after thrombolysis in acute ST-elevation myocardial infarction: a meta-analysis.
    D'Souza SP; Mamas MA; Fraser DG; Fath-Ordoubadi F
    Eur Heart J; 2011 Apr; 32(8):972-82. PubMed ID: 21036776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of cardiac care variation on ST-elevation myocardial infarction outcomes in Malaysia.
    Selvarajah S; Fong AY; Selvaraj G; Haniff J; Hairi NN; Bulgiba A; Bots ML
    Am J Cardiol; 2013 May; 111(9):1270-6. PubMed ID: 23415636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.